导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -9.29% | 812/1050 |
| 近一周 | -3.32% | 857/1104 |
| 近一月 | -6.22% | 749/1102 |
| 近一季 | -10.72% | 693/1092 |
| 近半年 | -17.80% | 950/1070 |
| 近一年 | -4.73% | 648/1018 |
| 近两年 | 8.57% | 844/926 |
| 近三年 | -18.32% | 764/834 |
| 成立以来 | 61.42% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
2.34% 311/1070 |
0.33% 691/1101 |
- - |
- - |
| 2025 | 13.31% 782/1065 |
-5.20% 989/1014 |
-5.47% 966/1038 |
28.71% 379/1050 |
-1.75% 545/1065 |
| 2024 | -15.48% 869/1011 |
-5.89% 608/960 |
-18.95% 952/983 |
31.16% 3/991 |
-15.52% 980/1011 |
| 2023 | -40.75% 843/952 |
-8.70% 845/880 |
-5.02% 521/895 |
-25.51% 887/915 |
-8.28% 782/952 |
| 2022 | -22.70% 427/867 |
-17.20% 372/773 |
6.77% 421/806 |
-6.34% 91/845 |
-6.63% 690/867 |
| 2021 | 26.14% 103/740 |
7.35% 25/580 |
1.33% 525/659 |
9.51% 72/704 |
5.89% 188/740 |
| 2020 | 133.83% 2/554 |
7.61% 51/419 |
38.91% 33/466 |
30.89% 5/517 |
19.50% 127/554 |
| 2019 | 65.31% 56/410 |
26.58% 582/1146 |
-1.46% 480/1228 |
15.24% 35/390 |
15.00% 55/410 |
| 2018 | -36.51% 269/349 |
- - |
-15.00% 764/990 |
-10.75% 787/1000 |
-10.95% 380/1080 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8316 | 54.00% |
| 招商前沿医疗保健股票C | 0.7978 | 53.69% |
| 招商医药健康产业股票 | 2.5730 | 48.73% |
| 嘉实医疗保健股票 | 2.5780 | 39.05% |
| 广发医药精选股票A | 1.3132 | 38.48% |
| 广发医药精选股票C | 1.2923 | 38.32% |
| 前海开源公共卫生股票A | 0.4690 | 37.42% |
| 前海开源公共卫生股票C | 0.4590 | 37.30% |
| 交银医药创新股票C | 3.0594 | 35.86% |
| 交银医药创新股票A | 2.8810 | 32.85% |
| 广发高端制造股票A VS. 东吴新产业精选股票A(580008) |